FGF21 and Graves disease: On a larger population of Graves’ disease patients with overt hyperthyroidism, Xiao et al. showed elevated serum FGF21 levels and found a decline after reaching euthyroid hormone levels; simultaneously, the patients’ BMI elevated but remained in the normal range.